| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/27/2002 | EP1082091B1 Use of micro-organism extracts in cosmetic or pharmaceutical compositions |
| 03/27/2002 | EP0796102B1 A composition for treating endometriosis, containing a precious metal salt and mel cum sale |
| 03/27/2002 | EP0782452B1 Cell growth regulator |
| 03/27/2002 | CN1342264A Heart abnormalities in vascular endothelial growth factor B(VEGF-B) deficient animals and methods relating to these heart abnormalities |
| 03/27/2002 | CN1342196A Bifidobacterium in treatment of inflammatory disease |
| 03/27/2002 | CN1342155A Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 03/27/2002 | CN1342096A Synergistic tumorcidal response induced by histamine |
| 03/27/2002 | CN1341662A Scorpion pain-stopping anti-tumor Val-Arg-Gly peptide and its preparation method |
| 03/27/2002 | CN1341445A Yanhou Longhusan powder for curing sore-throat and laryngopharyngitis |
| 03/27/2002 | CN1341437A Chinese herbal medicine composition prescription for curing liver disease and its preparation method |
| 03/27/2002 | CN1341432A Brain-tonifying intelligence-raising granules |
| 03/27/2002 | CN1341422A Freeze-dried scorpion |
| 03/27/2002 | CN1341421A Shaliwikang soft capsule |
| 03/27/2002 | CN1341378A Instant breast-tonifying powder and its preparation method |
| 03/27/2002 | CN1081466C Powder for relieving cough and asthma |
| 03/27/2002 | CN1081464C Chinese medicine for acute and chronic diarrhea, dysentery with purulent and bloody stools, as well as acute and chronic colitis |
| 03/27/2002 | CN1081463C External use medicine for vitiligo |
| 03/27/2002 | CN1081447C Process for keeping royal jelly activity |
| 03/26/2002 | US6362001 Establishing a culture of drosophila cells; transfecting with expressible class 1 mhc heavy chain gene linked to promoter; transfecting with an expressible .beta.-2 microglobulin gene and with assisting molecule gene, mixing with peptide |
| 03/26/2002 | US6361997 Genetically modified CD34-negative adherently growing stem cells and their use in gene therapy |
| 03/26/2002 | US6361771 Implantable cell culture device comprising semipermeable membrane permitting diffusion of growth factor therethrough, and arpe-19 cells genetically engineered to produce growth factor disposed within semipermeable membrane |
| 03/26/2002 | US6361770 Introducing ex vivo nucleic acid molecule comprising sequence encoding tap-1 into tumor cell, expressing tap-1 in tumor cell, permitting recognition of tumor by mammal's immune response, introducing tumor cell into mammal |
| 03/26/2002 | US6361692 On line blood processing system for obtaining for storage a blood suspension having a reduced residual leukocyte population |
| 03/26/2002 | CA2180570C Isolated p27 protein and its encoding nucleic acid molecules |
| 03/21/2002 | WO2002022795A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | WO2002022790A1 T cell receptor transfer into a candidate effector cell or a precursor thereof |
| 03/21/2002 | WO2002022789A1 Process for producing normal parenchymal cells, tissue or organ by bioincubator |
| 03/21/2002 | WO2002022787A2 Differential treatment of selected parts of a single cell with different fluid components |
| 03/21/2002 | WO2002022680A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 03/21/2002 | WO2002022664A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/21/2002 | WO2002022656A2 An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof |
| 03/21/2002 | WO2002022648A2 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | WO2002022573A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | WO2002022175A2 Method and composition for treating tumors by selective induction of apoptosis |
| 03/21/2002 | WO2002022169A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS |
| 03/21/2002 | WO2002022151A2 Use of glp-1 and flp-2 peptides for treatment of bone disorders |
| 03/21/2002 | WO2002022149A1 Use of il-6r/il-6 chimera in huntington's disease |
| 03/21/2002 | WO2002022114A2 Methods and compositions for the treatment and prevention of sexual dysfunction |
| 03/21/2002 | WO2002022107A2 Pharmaceutical composition having modified carrier |
| 03/21/2002 | WO2002022080A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/21/2002 | WO2001087039A3 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2 |
| 03/21/2002 | WO2001077303A3 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 03/21/2002 | WO2001057534A3 Compositions and methods for reducing autoimmunity |
| 03/21/2002 | WO2001032840A3 Hair transplantation |
| 03/21/2002 | WO2001030375A3 Use of gdnf for treating corneal defects |
| 03/21/2002 | WO2001010199A9 A knockout mouse for the tumor suppressor gene anx7 |
| 03/21/2002 | WO2000041484A8 Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 03/21/2002 | US20020035737 Cloning pigs using donor nuclei from differentiated cells |
| 03/21/2002 | US20020035735 Reproducing and animal; obtain preferential embryonic cells, culture cells, transfer cells to primate, recover infant |
| 03/21/2002 | US20020035394 Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
| 03/21/2002 | US20020035356 Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancer |
| 03/21/2002 | US20020034820 Sebocytes, sebocyte-cell line and uses thereof |
| 03/21/2002 | US20020034819 Generating differentiated aggregates; obtain sample, incubate in propagation broth, recover generated tissues |
| 03/21/2002 | US20020034809 Process for producing a plasma protein-containing medicament |
| 03/21/2002 | US20020034779 Novel argS |
| 03/21/2002 | US20020034523 Immunogenic preparation and method for improving the productivity of ruminant animals |
| 03/21/2002 | US20020034519 Modified bovine adenovirus having altered tropism |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | US20020034504 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 03/21/2002 | US20020034501 Methods and compositions for promoting angiogenesis using monocytes |
| 03/21/2002 | US20020034500 Regulatory T cells; methods |
| 03/21/2002 | US20020034495 Gene therapy |
| 03/21/2002 | US20020034485 Mixture of fatty acid, biotin and caffeine |
| 03/21/2002 | US20020034393 Vector |
| 03/21/2002 | CA2774204A1 Method for treating a patient using a cultured connective tissue construct |
| 03/21/2002 | CA2422882A1 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | CA2422762A1 Differential treatment of selected parts of a single cell with different fluid components |
| 03/21/2002 | CA2422603A1 Vectors for molecule delivery to cd11b expressing cells |
| 03/21/2002 | CA2422597A1 T cell receptor transfer into a candidate effector cell or a precursor thereof |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2422454A1 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | CA2422246A1 Methods and compositions for the treatment and prevention of sexual dysfunction |
| 03/21/2002 | CA2422163A1 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | CA2421585A1 Method and composition for treating tumors by selective induction of apoptosis |
| 03/21/2002 | CA2391407A1 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/21/2002 | CA2357549A1 Assay for identifying modulators of chondrogenesis |
| 03/20/2002 | EP1189061A1 Multifunctional erythrocyte reagent containing carbamates and uses |
| 03/20/2002 | EP1188827A1 Processes for the fusion of dendritic cells with tumor cells and media for such processes |
| 03/20/2002 | EP1188825A1 T cell receptor transfer into a candidate effector cell or a precursor thereof |
| 03/20/2002 | EP1188446A1 Proteinaceous vectors for molecule delivery to CD11b expressing cells |
| 03/20/2002 | EP1187923A1 Apoptosis inhibition by adenovirus e3/6.7k |
| 03/20/2002 | EP1187919A2 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 03/20/2002 | EP1187911A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 03/20/2002 | EP1187909A2 Fabrication of vascularized tissue using microfabricated two-dimensional molds |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 03/20/2002 | EP1187637A2 Alpha or beta emitters attached to fragments in radioimmunotherapy |
| 03/20/2002 | EP1187622A1 Method of sterilizing |
| 03/20/2002 | EP1187530A1 Improved storage and maintenance of blood products including red blood cells and platelets |
| 03/20/2002 | EP1058563A4 Systems and methods for obtaining a uniform targeted volume of concentrated red blood cells |
| 03/20/2002 | EP0778778B1 Probiotic compositions |
| 03/20/2002 | EP0670726B1 Treatment of hiv infection with humic acid |
| 03/20/2002 | EP0642351B1 New pharmaceutical uses of krill enzymes |
| 03/20/2002 | EP0591385B1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 03/20/2002 | CN1341121A Expression and export of anti-obesity proteins as Fc fusion proteins |
| 03/20/2002 | CN1341029A Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomas |
| 03/20/2002 | CN1340350A Chewing medicine for treating facial paralysis and its preparing process |
| 03/20/2002 | CN1340346A Medical wine for replenishing vital essence and invigorating vital function and its preparing process |
| 03/20/2002 | CN1340345A Orally-applied medicine for treating hyperosteogeny |